170 related articles for article (PubMed ID: 17767803)
1. A double blind, placebo-controlled cross over trial of cellulose powder by nasal provocation with Der p1 and Der f1.
Emberlin JC; Lewis RA
Curr Med Res Opin; 2007 Oct; 23(10):2423-31. PubMed ID: 17767803
[TBL] [Abstract][Full Text] [Related]
2. Pollen challenge study of a phototherapy device for reducing the symptoms of hay fever.
Emberlin JC; Lewis RA
Curr Med Res Opin; 2009 Jul; 25(7):1635-44. PubMed ID: 19476405
[TBL] [Abstract][Full Text] [Related]
3. Targeting adenosine receptors in the treatment of allergic rhinitis: a randomized, double-blind, placebo-controlled study.
Rimmer J; Peake HL; Santos CM; Lean M; Bardin P; Robson R; Haumann B; Loehrer F; Handel ML
Clin Exp Allergy; 2007 Jan; 37(1):8-14. PubMed ID: 17210036
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of the efficacy of specific immunotherapy with house-dust mite extracts in adults with allergic rhinitis and/or asthma].
Polzehl D; Keck T; Riechelmann H
Laryngorhinootologie; 2003 Apr; 82(4):272-80. PubMed ID: 12717603
[TBL] [Abstract][Full Text] [Related]
5. The effect of local nasal immunotherapy in allergic rhinitis: using strips of the allergen dermatophagoides pteronyssinus.
Tsai JJ; Liao EC; Tsai FH; Hsieh CC; Lee MF
J Asthma; 2009 Mar; 46(2):165-70. PubMed ID: 19253124
[TBL] [Abstract][Full Text] [Related]
6. A double blind, placebo controlled trial of inert cellulose powder for the relief of symptoms of hay fever in adults.
Emberlin JC; Lewis RA
Curr Med Res Opin; 2006 Feb; 22(2):275-85. PubMed ID: 16466599
[TBL] [Abstract][Full Text] [Related]
7. A placebo-controlled evaluation of butterbur and fexofenadine on objective and subjective outcomes in perennial allergic rhinitis.
Lee DK; Gray RD; Robb FM; Fujihara S; Lipworth BJ
Clin Exp Allergy; 2004 Apr; 34(4):646-9. PubMed ID: 15080820
[TBL] [Abstract][Full Text] [Related]
8. Effects of a new formulation of olopatadine ophthalmic solution on nasal symptoms relative to placebo in two studies involving subjects with allergic conjunctivitis or rhinoconjunctivitis.
Abelson MB; Gomes PJ; Vogelson CT; Pasquine TA; Turner FD; Wells DT; Robertson SM
Curr Med Res Opin; 2005 May; 21(5):683-91. PubMed ID: 15969867
[TBL] [Abstract][Full Text] [Related]
9. Onset of action of intranasal budesonide (Rhinocort aqua) in seasonal allergic rhinitis studied in a controlled exposure model.
Day JH; Briscoe MP; Rafeiro E; Ellis AK; Pettersson E; Akerlund A
J Allergy Clin Immunol; 2000 Mar; 105(3):489-94. PubMed ID: 10719298
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of an intranasal house dust mite provocation model as a tool in clinical research.
Oldenbeuving NB; KleinJan A; Mulder PG; Lumley P; de Groot EJ; van Drunen CM; Fokkens WJ
Allergy; 2005 Jun; 60(6):751-9. PubMed ID: 15876304
[TBL] [Abstract][Full Text] [Related]
11. Effects of single or combined histamine H1-receptor and leukotriene CysLT1-receptor antagonism on nasal adenosine monophosphate challenge in persistent allergic rhinitis.
Lee DK; Jackson CM; Soutar PC; Fardon TC; Lipworth BJ
Br J Clin Pharmacol; 2004 Jun; 57(6):714-9. PubMed ID: 15151516
[TBL] [Abstract][Full Text] [Related]
12. Randomized double-blind placebo-controlled trial of sublingual immunotherapy in children with house dust mite allergy in primary care: study design and recruitment.
de Bot CM; Moed H; Berger MY; Röder E; de Groot H; de Jongste JC; van Wijk RG; van der Wouden JC
BMC Fam Pract; 2008 Oct; 9():59. PubMed ID: 18937864
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of impermeable covers for bedding in patients with allergic rhinitis.
Terreehorst I; Hak E; Oosting AJ; Tempels-Pavlica Z; de Monchy JG; Bruijnzeel-Koomen CA; Aalberse RC; Gerth van Wijk R
N Engl J Med; 2003 Jul; 349(3):237-46. PubMed ID: 12867607
[TBL] [Abstract][Full Text] [Related]
14. A nasally applied cellulose powder in seasonal allergic rhinitis in adults with grass pollen allergy: a double-blind, randomized, placebo-controlled, parallel-group study.
Åberg N; Ospanova ST; Nikitin NP; Emberlin J; Dahl Å
Int Arch Allergy Immunol; 2014; 163(4):313-8. PubMed ID: 24852424
[TBL] [Abstract][Full Text] [Related]
15. Effects of intranasal corticosteroid on nasal adenosine monophosphate challenge in persistent allergic rhinitis.
Barnes ML; Biallosterski BT; Fujihara S; Gray RD; Fardon TC; Lipworth BJ
Allergy; 2006 Nov; 61(11):1319-25. PubMed ID: 17002709
[TBL] [Abstract][Full Text] [Related]
16. A nasally applied cellulose powder in seasonal allergic rhinitis (SAR) in children and adolescents; reduction of symptoms and relation to pollen load.
Åberg N; Dahl Å; Benson M
Pediatr Allergy Immunol; 2011 Sep; 22(6):594-9. PubMed ID: 21645117
[TBL] [Abstract][Full Text] [Related]
17. Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy.
Tonnel AB; Scherpereel A; Douay B; Mellin B; Leprince D; Goldstein N; Delecluse P; Andre C
Allergy; 2004 May; 59(5):491-7. PubMed ID: 15080829
[TBL] [Abstract][Full Text] [Related]
18. A proof-of-concept study to assess the putative dose response to topical corticosteroid in persistent allergic rhinitis using adenosine monophosphate challenge.
Barnes ML; Menzies D; Nair AR; Hopkinson PJ; Lipworth BJ
Clin Exp Allergy; 2007 May; 37(5):696-703. PubMed ID: 17456217
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of mometasone furoate nasal spray in the treatment of allergic rhinitis. Meta-analysis of randomized, double-blind, placebo-controlled, clinical trials.
Penagos M; Compalati E; Tarantini F; Baena-Cagnani CE; Passalacqua G; Canonica GW
Allergy; 2008 Oct; 63(10):1280-91. PubMed ID: 18721246
[TBL] [Abstract][Full Text] [Related]
20. Are prostaglandins major mediators in perennial allergic rhinitis?
Lee WC; Morgan DW; Marriott JF
Rhinology; 1996 Sep; 34(3):130-5. PubMed ID: 8938878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
